Ophthalmic Disease Therapeutics Market Research with Analyst Recommendations - Focus on Rare Eye Diseases / Growing Role of Artificial Intelligence in Diagnosis and Treatment - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Ophthalmic Disease Therapeutics Market (2024 Edition): Analysis By Indication (Age-related macular degeneration, Diabetic macular edema, Other retinal disorders), By Therapies, By Distribution Channel, By Region, By Country: Market Insights and Forecast (2020-2030)" report has been added to ResearchAndMarkets.com's offering.

The Global Ophthalmic Disease Therapeutics market showcased growth at a CAGR of 3.81% during 2020-2023. The market was valued at USD 21.92 Billion in 2023 which is expected to reach USD 31.67 Billion in 2030. This report provides analysis for the historical period of 2020-2023, the estimates of 2024 and the forecast period of 2025-2030.

The report tracks competitive developments, strategies, mergers and acquisitions and new product development. The companies analyzed in the report include Horizon Therapeutics, Viridian Therapeutics, Viatris, Sanofi Novartis, Bayer AG, Teva Pharmaceuticals, F. Hoffmann-La Roche AG, AbbVie, and GSK plc.

The global ophthalmic disease therapeutics market is projected to exhibit robust growth during the forecast period. Factors such as the introduction of innovative treatment options, rising disposable incomes, and expanding healthcare infrastructure are anticipated to propel market expansion.

The rising incidence of lifestyle-related eye diseases, such as diabetic retinopathy and computer vision syndrome, is contributing to market expansion. Advancements in ophthalmic research and development have led to the development of novel therapies, thereby creating new growth opportunities. Additionally, increasing healthcare expenditure and rising disposable incomes are enabling greater access to ophthalmic care, further stimulating market growth.

Moreover, public health initiatives and increased awareness about eye diseases are improving early diagnosis and treatment, particularly in developed regions.

Global Ophthalmic Disease Therapeutics Market: Historic and Forecast

Impact Analysis of Macro Economic Factors on Ophthalmic Disease Therapeutics Market

• Age wise prevalence of Glaucoma
• Global Prevalence of Ophthalmic Diseases, 2021
• Prevalence of Age-related macular degeneration, 2021
• Global Ophthalmic Disease Therapeutics Market: Dashboard
• Global Ophthalmic Disease Therapeutics Market: Market Size and CAGR, 2020-2030 (USD Billion & CAGR)
• Global Ophthalmic Disease Therapeutics Market: Market Value Assessment
• Assessment Degree of Impact of COVID-19 on Global Ophthalmic Disease Therapeutics Market

Global Ophthalmic Disease Therapeutics Market Segmentation: By Indication

• Global Ophthalmic Disease Therapeutics Market, By Indication Overview
• Global Ophthalmic Disease Therapeutics Market Attractiveness Index, By Indication
• Global Ophthalmic Disease Therapeutics Market Size, By Age-related macular degeneration , By Value, 2020H-2030F (USD Billion & CAGR)
• Global Ophthalmic Disease Therapeutics Market Size, By Diabetic macular edema, By Value, 2020H-2030F (USD Billion & CAGR)
• Global Ophthalmic Disease Therapeutics Market Size, By Other retinal disorders , By Value, 2020H-2030F (USD Billion & CAGR)
• Global Ophthalmic Disease Therapeutics Market Segmentation: By Therapies

Global Ophthalmic Disease Therapeutics Market, By Therapies Overview

• Global Ophthalmic Disease Therapeutics Market Attractiveness Index, By Therapies
• Global Ophthalmic Disease Therapeutics Market Size, By Anti VEGF, By Value, 2020H-2030F (USD Billion & CAGR)
• Global Ophthalmic Disease Therapeutics Market Size, By Antibody - anti-IGF-1R, By Value, 2020H-2030F (USD Billion & CAGR)
• Global Ophthalmic Disease Therapeutics Market Size, By Eye drops, By Value, 2020H-2030F (USD Billion & CAGR)
• Global Ophthalmic Disease Therapeutics Market Size, By Other Therapies, By Value, 2020H-2030F (USD Billion & CAGR)

Global Ophthalmic Disease Therapeutics Market Segmentation: By Distribution Channel

• Global Ophthalmic Disease Therapeutics Market, By Distribution Channel Overview
• Global Ophthalmic Disease Therapeutics Market Attractiveness Index, By Distribution Channel
• Global Ophthalmic Disease Therapeutics Market Size, By Hospital Pharmacies, By Value, 2020H-2030F (USD Billion & CAGR)
• Global Ophthalmic Disease Therapeutics Market Size, By Retail & Online Pharmacies, By Value, 2020H-2030F (USD Billion & CAGR)

Analyst Recommendations

• Focus on Rare Eye Diseases
• Growing Role of Artificial Intelligence in Diagnosis and Treatment

Competitive Positioning

• Companies' Product Positioning
• Market Position Matrix
• Market Share Analysis of Ophthalmic Disease Therapeutics Market

Company Profiles

• Horizon Therapeutics
• Viridian Therapeutics
• Viatris
• Sanofi
• Novartis AG
• Bayer AG
• Teva Pharmaceuticals
• F. Hoffmann-La Roche AG
• AbbVie
• GSK plc

For more information about this report visit https://www.researchandmarkets.com/r/t6kyvj

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.